Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options

被引：15
作者：
Licitra, L. [1 ]
Locati, L. D. [1 ]
Bossi, P. [1 ]
机构：
[1] Ist Nazl Tumori, Fdn IRCCS, Head & Neck Med Oncol Unit, Dept Med Oncol, I-20133 Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
10.1093/annonc/mdn456
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 203
页数：4
相关论文
共 44 条
[1]  
ABIDOYE C, 2006, J CLIN ONCOL, V24
[2]  
Ang KK, 2002, CANCER RES, V62, P7350
[3]   Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck - An analysis of two Eastern Cooperative Oncology Group randomized trials [J].
Argiris, A ;
Li, Y ;
Forastiere, A .
CANCER, 2004, 101 (10) :2222-2229
[4]   Phase II multicenter study of the antiepidermal growth factor receptor monoclonal antibody cetuximab in combination with platinum-based chemotherapy in patients with platinum-refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck [J].
Baselga, J ;
Trigo, JM ;
Bourhis, J ;
Tortochaux, J ;
Cortés-Funes, H ;
Hitt, R ;
Gascón, P ;
Arnellal, N ;
Harstrick, A ;
Eckardt, A .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5568-5577
[5]  
Belón J, 2005, J CLIN ONCOL, V23, p515S
[6]   Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: An eastern cooperative oncology group study [J].
Burtness, B ;
Goldwasser, MA ;
Flood, W ;
Mattar, B ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8646-8654
[7]   DOCETAXEL (TAXOTERE(R)) - AN ACTIVE-DRUG FOR THE TREATMENT OF PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].
CATIMEL, G ;
VERWEIJ, J ;
MATTIJSSEN, V ;
HANAUSKE, A ;
PICCART, M ;
WANDERS, J ;
FRANKLIN, H ;
LEBAIL, N ;
CLAVEL, M ;
KAYE, SB .
ANNALS OF ONCOLOGY, 1994, 5 (06) :533-537
[8]   Increased epidermal growth factor receptor gene copy number is associated with poor prognosis in head and neck squamous cell carcinomas [J].
Chung, Christine H. ;
Ely, Kim ;
McGavran, Loris ;
Varella-Garcia, Marileila ;
Parker, Joel ;
Parker, Natalie ;
Jarrett, Carolyn ;
Carter, Jesse ;
Murphy, Barbara A. ;
Netterville, James ;
Burkey, Brian B. ;
Sinard, Robert ;
Cmelak, Anthony ;
Levy, Shawn ;
Yarbrough, Wendell G. ;
Slebos, Robbert J. C. ;
Hirsch, Fred R. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (25) :4170-4176
[9]   Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck [J].
Cohen, EEW ;
Rosen, F ;
Stadler, WM ;
Recant, W ;
Stenson, K ;
Huo, DZ ;
Vokes, EE .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (10) :1980-1987
[10]   Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck [J].
Cohen, EEW ;
Kane, MA ;
List, MA ;
Brockstein, BE ;
Mehrotra, B ;
Huo, DZ ;
Mauer, AM ;
Pierce, C ;
Dekker, A ;
Vokes, EE .
CLINICAL CANCER RESEARCH, 2005, 11 (23) :8418-8424
12345